Tcl1 peptides for immunotherapy
作者： Sattva S. Neelapu , Jinsheng Weng
DOI:
关键词:
摘要: Provided are TCLl peptides that bind to MHC I (HLA-A2) on tumor cells or other antigen-presenting and recognized by T-cell receptors T cells. The may be therapeutically used treat a cancer, such as B cell malignancy, leukemia, lymphoma. Methods for expanding population of target also provided.
lens.org 参考文章(60)
Catherine Gritti, Hélène Dastot, Jean Soulier, Anne Janin, Marie-Thérèse Daniel, Ali Madani, Gisèle Grimber, Pascale Briand, François Sigaux, Marc-Henri Stern, Transgenic Mice for MTCP1 Develop T-Cell Prolymphocytic Leukemia Blood. ,vol. 92, pp. 368- 373 ,(1998) , 10.1182/BLOOD.V92.2.368
Martijn S. Bijker, Susan J. F. van den Eeden, Kees L. Franken, Cornelis J. M. Melief, Rienk Offringa, Sjoerd H. van der Burg, CD8+ CTL Priming by Exact Peptide Epitopes in Incomplete Freund’s Adjuvant Induces a Vanishing CTL Response, whereas Long Peptides Induce Sustained CTL Reactivity Journal of Immunology. ,vol. 179, pp. 5033- 5040 ,(2007) , 10.4049/JIMMUNOL.179.8.5033
Maurizio Bendandi, Christopher D. Gocke, Carol B. Kobrin, Floyd A. Benko, Lars A. Sternas, Robin Pennington, Thelma M. Watson, Craig W. Reynolds, Barry L. Gause, Patricia L. Duffey, Elaine S. Jaffe, Stephen P. Creekmore, Dan L. Longo, Larry W. Kwak, Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma. Nature Medicine. ,vol. 5, pp. 1171- 1177 ,(1999) , 10.1038/13928
Sander Zwaveling, Sandra C. Ferreira Mota, Jan Nouta, Mark Johnson, Grayson B. Lipford, Rienk Offringa, Sjoerd H. van der Burg, Cornelis J. M. Melief, Established Human Papillomavirus Type 16-Expressing Tumors Are Effectively Eradicated Following Vaccination with Long Peptides Journal of Immunology. ,vol. 169, pp. 350- 358 ,(2002) , 10.4049/JIMMUNOL.169.1.350
Anatoli Malyguine, Susan L Strobl, Kimberly A Shafer-Weaver, Tracy Ulderich, Angela Troke, Michael Baseler, Larry W Kwak, Sattva S Neelapu, A modified human ELISPOT assay to detect specific responses to primary tumor cell targets Journal of Translational Medicine. ,vol. 2, pp. 9- 9 ,(2004) , 10.1186/1479-5876-2-9
Carlo M. Croce, Yuri Pekarsky, TCL-1b GENE AND PROTEIN AND RELATED METHODS AND COMPOSITIONS ,(2000)
Carlo M. Croce, Giandomenico Russo, TCL-1 protein and related methods ,(1999)
Richard Harrop, Susan Kingsman, Miles Carroll, MHC class II epitopes of 5T4 antigen ,(2003)
P McLaughlin, A J Grillo-López, B K Link, R Levy, M S Czuczman, M E Williams, M R Heyman, I Bence-Bruckler, C A White, F Cabanillas, V Jain, A D Ho, J Lister, K Wey, D Shen, B K Dallaire, Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program. Journal of Clinical Oncology. ,vol. 16, pp. 2825- 2833 ,(1998) , 10.1200/JCO.1998.16.8.2825
Antonella Stoppacciaro, Anna Maria Lavinia, Maria Grazia Narducci, Edoardo Pescarmona, Sabina Signoretti, Cristina Lazzeri, Enrico Scala, Carlo David Baroni, Carlo Maria Croce, Giandomenico Russo, Daniele Remotti, Regulation of TCL1 Expression in B- and T-Cell Lymphomas and Reactive Lymphoid Tissues Cancer Research. ,vol. 60, pp. 2095- 2100 ,(2000)